Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Chen MB, Wu XY, Shen W, Wei MX, Li C, Cai B, Tao GQ, Lu PH (2011) Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62, 005 subjects. Breast Cancer Res Treat 126:177–183PubMedCrossRef
2.
Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI et al (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4:e1000054PubMedCrossRef
3.
Boccia S, De Feo E, Gallì P, Gianfagna F, Amore R, Ricciardi G (2010) A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol 25:765–775PubMedCrossRef
4.
Wang J, Wang B, Bi J, Di J (2010) The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi:10.​1007/​s10549-010-1314-0
5.
Lu S, Wang Z, Cui D, Liu H, Hao X (2011) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34, 658 subjects. Breast Cancer Res Treat 125:253–259PubMedCrossRef
Metadata
Title
Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk
Author
Weidong Chen
Publication date
01-08-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1501-7

Other articles of this Issue 1/2011

Breast Cancer Research and Treatment 1/2011 Go to the issue

Clinical Trial

Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment

Preclinical study

Effects of estrogen on the proportion of stem cells in the breast

Epidemiology

Mouse mammary tumor like virus sequences in breast milk from healthy lactating women

Letter to the Editor

Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study

Epidemiology

Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer

Preclinical study

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits